Wilkes University NSG 533 Exam 1: Advanced Pharmacology
Practice Questions & Answers Explanation | 2026/2027
Edition | 150 Verified Questions - 74 Questions with Answers
NSG 533 Exam 1 Advanced Pharmacology 2026-74 QUESTIONS AND ANSWERS ALREADY GRADED A+.
100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document for Wilkes University NSG 533 Exam 1 focuses on
advanced pharmacology principles essential for advanced practice nursing. It includes 150 verified
practice questions with detailed rationales, covering pharmacokinetics, pharmacodynamics, and
clinical application across major drug classes. Designed to reinforce critical thinking and safe
prescribing practices, this resource aligns with the latest 2026/2027 academic guidelines and
evidence-based standards. Ideal for graduate nursing students seeking to excel in their pharmacology
coursework and prepare for board certification.
Key Features:
Pharmacokinetics and Pharmacodynamics
Autonomic Nervous System Drugs
Cardiovascular Pharmacology
Antimicrobial Therapy
Endocrine and Metabolic Agents
Pain Management and Analgesics
Updates for 2026:
- Updated to reflect 2026/2027 clinical practice guidelines
- Incorporated latest FDA drug approvals and safety alerts
- Revised rationales to emphasize evidence-based prescribing
- Added new questions on emerging pharmacotherapies
- Aligned with current advanced pharmacology competencies
Abstract:
This exam preparation document for Wilkes University NSG 533 Exam 1 provides a rigorous review of advanced
pharmacology concepts essential for graduate-level nursing practice. The content is meticulously organized to
cover core areas including pharmacokinetic principles, pharmacodynamic interactions, and therapeutic
decision-making across diverse patient populations. Each of the 150 practice questions is accompanied by a
detailed explanation that not only identifies the correct answer but also analyzes distractors to deepen
understanding. The material is updated to reflect the latest 2026/2027 standards, ensuring relevance to current
clinical practice. Emphasis is placed on safe prescribing, drug interactions, adverse effects, and monitoring
parameters, which are critical for advanced practice nurses. This resource serves as an invaluable tool for exam
readiness and lifelong learning in pharmacotherapeutics.
Keywords:
Advanced Pharmacology, NSG 533, Exam 1, Pharmacokinetics, Pharmacodynamics, Prescribing, Drug
Interactions, Nursing Practice
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is followed by a
comprehensive rationale explaining the underlying pharmacological principle, and incorrect options are analyzed to
clarify common misconceptions. This approach reinforces learning and enhances clinical reasoning.
Page 1
,Compliance Checklist:
Aligned with 2026/2027 academic standards
Verified by subject matter experts
Includes evidence-based rationales
Covers all major exam topics
Suitable for graduate-level nursing students
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacokinetics and 1-30 Absorption, Distribution, Metabolism, 20%
Pharmacodynamics Excretion, Receptor Theory, Dose-Response
Autonomic Nervous System 31-50 Cholinergic Agonists/Antagonists, 13%
Drugs Adrenergic Agonists/Antagonists, Clinical
Applications
Cardiovascular Pharmacology 51-80 Antihypertensives, Antiarrhythmics, 20%
Anticoagulants, Antiplatelets,
Lipid-Lowering Agents
Antimicrobial Therapy 81-105 Antibiotics, Antivirals, Antifungals, 17%
Resistance Mechanisms, Selection of
Therapy
Endocrine and Metabolic Agents 106-125 Insulin, Oral Hypoglycemics, Thyroid 13%
Medications, Corticosteroids, Osteoporosis
Agents
Pain Management and 126-150 Opioids, NSAIDs, Adjuvant Analgesics, 17%
Analgesics Neuropathic Pain, Addiction and Tolerance
Page 2
,Q1. A drug has a volume of distribution of 40 L and a clearance of 4 L/hr. If the
therapeutic range is 2-10 mg/L, what is the most appropriate intravenous loading
dose to achieve a peak concentration of 10 mg/L?
A. 40 mg
B. 80 mg
C. 160 mg
D. 400 mg
Correct Answer: D. 400 mg
Rationale: Loading dose = Vd × target concentration = 40 L × 10 mg/L = 400 mg. This
ensures rapid attainment of therapeutic levels.
Why Wrong:
A - Ignores the volume of distribution and target concentration.
B - Incorrectly uses half the target concentration.
C - Misapplies the formula, possibly using clearance instead of Vd.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 4
Q2. Which of the following pharmacodynamic principles best explains why a partial
agonist can act as an antagonist in the presence of a full agonist?
A. It has higher affinity but lower intrinsic efficacy.
B. It has lower affinity but higher intrinsic efficacy.
C. It binds to a different receptor subtype.
D. It increases the metabolism of the full agonist.
Correct Answer: A. It has higher affinity but lower intrinsic efficacy.
Rationale: A partial agonist has high affinity but low intrinsic efficacy; it occupies
receptors without producing maximal effect, blocking the full agonist from binding and
thereby reducing the overall response.
Why Wrong:
B - Lower affinity would not effectively compete with the full agonist.
C - Different receptor subtype would not directly antagonize the full agonist's effect.
D - Metabolic interaction is not a pharmacodynamic mechanism.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 3
Q3. A patient with chronic neuropathic pain has been on gabapentin 900 mg three
times daily. Recent renal function decline (CrCl 30 mL/min) necessitates dose
adjustment. Which of the following is the most appropriate revised regimen?
A. 300 mg three times daily
B. 600 mg twice daily
C. 900 mg once daily
Page 3
, D. 300 mg once daily
Correct Answer: A. 300 mg three times daily
Rationale: Gabapentin is renally cleared. For CrCl 30-59 mL/min, the recommended dose
is 300-600 mg three times daily; starting at 300 mg TID is appropriate for this level of
renal impairment.
Why Wrong:
B - 600 mg twice daily may exceed the recommended total daily dose for this CrCl.
C - 900 mg once daily is too high for a single dose and not guideline-based.
D - 300 mg once daily is subtherapeutic for neuropathic pain.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 25
Q4. Which of the following drugs is most likely to cause a disulfiram-like reaction
when co-administered with alcohol?
A. Ciprofloxacin
B. Metronidazole
C. Azithromycin
D. Doxycycline
Correct Answer: B. Metronidazole
Rationale: Metronidazole inhibits acetaldehyde dehydrogenase, leading to accumulation
of acetaldehyde when alcohol is consumed, causing flushing, tachycardia, and nausea.
Why Wrong:
A - Ciprofloxacin does not typically cause disulfiram-like reactions.
C - Azithromycin has no such interaction.
D - Doxycycline is not associated with this effect.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 82
Q5. A patient on warfarin for atrial fibrillation is started on amiodarone. Which of
the following is the most appropriate management to prevent a bleeding
complication?
A. Increase warfarin dose by 50%
B. Reduce warfarin dose by 30-50%
C. Discontinue warfarin and switch to dabigatran
D. Monitor INR weekly without dose adjustment
Correct Answer: B. Reduce warfarin dose by 30-50%
Rationale: Amiodarone inhibits CYP2C9, reducing warfarin metabolism and increasing
INR. Warfarin dose should be reduced by 30-50% to avoid excessive anticoagulation.
Why Wrong:
A - Increasing the dose would worsen the risk of bleeding.
Page 4
Practice Questions & Answers Explanation | 2026/2027
Edition | 150 Verified Questions - 74 Questions with Answers
NSG 533 Exam 1 Advanced Pharmacology 2026-74 QUESTIONS AND ANSWERS ALREADY GRADED A+.
100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document for Wilkes University NSG 533 Exam 1 focuses on
advanced pharmacology principles essential for advanced practice nursing. It includes 150 verified
practice questions with detailed rationales, covering pharmacokinetics, pharmacodynamics, and
clinical application across major drug classes. Designed to reinforce critical thinking and safe
prescribing practices, this resource aligns with the latest 2026/2027 academic guidelines and
evidence-based standards. Ideal for graduate nursing students seeking to excel in their pharmacology
coursework and prepare for board certification.
Key Features:
Pharmacokinetics and Pharmacodynamics
Autonomic Nervous System Drugs
Cardiovascular Pharmacology
Antimicrobial Therapy
Endocrine and Metabolic Agents
Pain Management and Analgesics
Updates for 2026:
- Updated to reflect 2026/2027 clinical practice guidelines
- Incorporated latest FDA drug approvals and safety alerts
- Revised rationales to emphasize evidence-based prescribing
- Added new questions on emerging pharmacotherapies
- Aligned with current advanced pharmacology competencies
Abstract:
This exam preparation document for Wilkes University NSG 533 Exam 1 provides a rigorous review of advanced
pharmacology concepts essential for graduate-level nursing practice. The content is meticulously organized to
cover core areas including pharmacokinetic principles, pharmacodynamic interactions, and therapeutic
decision-making across diverse patient populations. Each of the 150 practice questions is accompanied by a
detailed explanation that not only identifies the correct answer but also analyzes distractors to deepen
understanding. The material is updated to reflect the latest 2026/2027 standards, ensuring relevance to current
clinical practice. Emphasis is placed on safe prescribing, drug interactions, adverse effects, and monitoring
parameters, which are critical for advanced practice nurses. This resource serves as an invaluable tool for exam
readiness and lifelong learning in pharmacotherapeutics.
Keywords:
Advanced Pharmacology, NSG 533, Exam 1, Pharmacokinetics, Pharmacodynamics, Prescribing, Drug
Interactions, Nursing Practice
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is followed by a
comprehensive rationale explaining the underlying pharmacological principle, and incorrect options are analyzed to
clarify common misconceptions. This approach reinforces learning and enhances clinical reasoning.
Page 1
,Compliance Checklist:
Aligned with 2026/2027 academic standards
Verified by subject matter experts
Includes evidence-based rationales
Covers all major exam topics
Suitable for graduate-level nursing students
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacokinetics and 1-30 Absorption, Distribution, Metabolism, 20%
Pharmacodynamics Excretion, Receptor Theory, Dose-Response
Autonomic Nervous System 31-50 Cholinergic Agonists/Antagonists, 13%
Drugs Adrenergic Agonists/Antagonists, Clinical
Applications
Cardiovascular Pharmacology 51-80 Antihypertensives, Antiarrhythmics, 20%
Anticoagulants, Antiplatelets,
Lipid-Lowering Agents
Antimicrobial Therapy 81-105 Antibiotics, Antivirals, Antifungals, 17%
Resistance Mechanisms, Selection of
Therapy
Endocrine and Metabolic Agents 106-125 Insulin, Oral Hypoglycemics, Thyroid 13%
Medications, Corticosteroids, Osteoporosis
Agents
Pain Management and 126-150 Opioids, NSAIDs, Adjuvant Analgesics, 17%
Analgesics Neuropathic Pain, Addiction and Tolerance
Page 2
,Q1. A drug has a volume of distribution of 40 L and a clearance of 4 L/hr. If the
therapeutic range is 2-10 mg/L, what is the most appropriate intravenous loading
dose to achieve a peak concentration of 10 mg/L?
A. 40 mg
B. 80 mg
C. 160 mg
D. 400 mg
Correct Answer: D. 400 mg
Rationale: Loading dose = Vd × target concentration = 40 L × 10 mg/L = 400 mg. This
ensures rapid attainment of therapeutic levels.
Why Wrong:
A - Ignores the volume of distribution and target concentration.
B - Incorrectly uses half the target concentration.
C - Misapplies the formula, possibly using clearance instead of Vd.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 4
Q2. Which of the following pharmacodynamic principles best explains why a partial
agonist can act as an antagonist in the presence of a full agonist?
A. It has higher affinity but lower intrinsic efficacy.
B. It has lower affinity but higher intrinsic efficacy.
C. It binds to a different receptor subtype.
D. It increases the metabolism of the full agonist.
Correct Answer: A. It has higher affinity but lower intrinsic efficacy.
Rationale: A partial agonist has high affinity but low intrinsic efficacy; it occupies
receptors without producing maximal effect, blocking the full agonist from binding and
thereby reducing the overall response.
Why Wrong:
B - Lower affinity would not effectively compete with the full agonist.
C - Different receptor subtype would not directly antagonize the full agonist's effect.
D - Metabolic interaction is not a pharmacodynamic mechanism.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 3
Q3. A patient with chronic neuropathic pain has been on gabapentin 900 mg three
times daily. Recent renal function decline (CrCl 30 mL/min) necessitates dose
adjustment. Which of the following is the most appropriate revised regimen?
A. 300 mg three times daily
B. 600 mg twice daily
C. 900 mg once daily
Page 3
, D. 300 mg once daily
Correct Answer: A. 300 mg three times daily
Rationale: Gabapentin is renally cleared. For CrCl 30-59 mL/min, the recommended dose
is 300-600 mg three times daily; starting at 300 mg TID is appropriate for this level of
renal impairment.
Why Wrong:
B - 600 mg twice daily may exceed the recommended total daily dose for this CrCl.
C - 900 mg once daily is too high for a single dose and not guideline-based.
D - 300 mg once daily is subtherapeutic for neuropathic pain.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 25
Q4. Which of the following drugs is most likely to cause a disulfiram-like reaction
when co-administered with alcohol?
A. Ciprofloxacin
B. Metronidazole
C. Azithromycin
D. Doxycycline
Correct Answer: B. Metronidazole
Rationale: Metronidazole inhibits acetaldehyde dehydrogenase, leading to accumulation
of acetaldehyde when alcohol is consumed, causing flushing, tachycardia, and nausea.
Why Wrong:
A - Ciprofloxacin does not typically cause disulfiram-like reactions.
C - Azithromycin has no such interaction.
D - Doxycycline is not associated with this effect.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 82
Q5. A patient on warfarin for atrial fibrillation is started on amiodarone. Which of
the following is the most appropriate management to prevent a bleeding
complication?
A. Increase warfarin dose by 50%
B. Reduce warfarin dose by 30-50%
C. Discontinue warfarin and switch to dabigatran
D. Monitor INR weekly without dose adjustment
Correct Answer: B. Reduce warfarin dose by 30-50%
Rationale: Amiodarone inhibits CYP2C9, reducing warfarin metabolism and increasing
INR. Warfarin dose should be reduced by 30-50% to avoid excessive anticoagulation.
Why Wrong:
A - Increasing the dose would worsen the risk of bleeding.
Page 4
